A recent study has once again found a possible link between telomere shortening and an increased risk of disease.
In a Thursday press release Life Length, a leading Spain-based biotechnology company specializing in the field of telomeres research technology, announced an agreement with Age Diagnostics Laboratories, Inc (“ADL”) to offer telomere testing nationwide in the US to both doctors and patients. This partnership will provide a location in the US where blood and tissue samples will be collected before being relayed to Life Length’s location in Europe for analysis.
Telome Health, Inc. (THINC), a biotechnology firm based in Menlo Park, CA has launched the beginning phase of a research study that will measure and analyze age-based average telomere lengths of Bay Area residents.
A new prospective study suggests that people who have white blood cells with shorter telomeres are at a higher risk of developing cancer. This research is the first of its kind to address the direct connection between telomeres and cancer. In what is known as the Bruneck Study, the telomeres of 787 subjects in England, Austria and Italy were monitored over the course of ten years.